The future for drug developers is increasingly shaped by how effectively they adapt to complexity, change and rising pressure across the development landscape.
To understand how the industry is responding, the PPD™ clinical research business of Thermo Fisher Scientific surveyed 150 leaders at biotech and pharmaceutical organizations worldwide for the fourth annual Pulse industry report. This year’s findings reveal a clear throughline: uncertainty is shaping decisions across R&D, from strategy and investment to execution.
In this webinar, industry experts will explore key signals from the 2026 Pulse research and discuss what they mean for navigating today’s evolving environment. Attendees will gain perspective on how peers are adapting their approaches to remain agile, manage risk and continue advancing innovation.
How are leading organizations making confident decisions when conditions remain unpredictable? Register for this webinar to gain insights that help navigate 2026 drug development with greater clarity and strategic focus.
Speakers
Daniel Jones, Vice President and General Manager, Internal Medicine Business Unit, The PPD Clinical Research Business of Thermo Fisher Scientific
Daniel serves as Vice President and General Manager for the PPD Clinical Research Business of Thermo Fisher Scientific, where he leads the Internal Medicine Business Unit. In this role, he develops and executes business growth strategies and champions enterprise initiatives to expand the therapeutic unit in cardiovascular, metabolic, immunology, dermatology, gastrointestinal, hepatology, genitourinary, nephrology and women’s health indications.
Daniel joined the business in 1999 and has amassed more than 26 years of experience, holding various roles with increasing responsibility in clinical operations, project management, strategic partnerships and development operations. Prior to his current position, he served as Vice President and Head of Clinical Operations for the Americas, where he led the regional start-up, clinical monitoring and clinical administration teams through significant growth. He developed successful recruitment and retention strategies and guided cross-functional initiatives focused on digital and remote solutions. Previously, as a pillar head for development operations leading strategic partnerships, Daniel provided direction in building and driving exceptional delivery and quality across multiple biopharma partnership accounts.
Daniel has therapeutic area expertise in oncology, hematology, infectious diseases, vaccines, nephrology, dermatology, immunology, cardiovascular and metabolic disorders. He also has extensive research operations experience in Phase I-IV trials. He holds a Bachelor’s degree in Biology and Chemistry from the University of North Carolina at Chapel Hill.
Message Presenter
Praveen Nadella, Head of Customer Insights & Intelligence, The PPD Clinical Research Business of Thermo Fisher Scientific
Praveen has more than 20 years of experience in the life sciences industry, both as a Consultant (IBM, Deloitte and Cognizant) and an industry professional (Shionogi, Grifols and GSK). His area of focus and expertise has been predominantly in the area of market research and customer insights, and building these competencies within organizations to truly drive customer-driven priorities and actions.
He has driven numerous insights-gathering efforts across multiple stakeholder groups, including patients, clinical trial sponsors, sites/investigators, HCPs, pharmacists and payers. Praveen currently serves as the Head of Customer Insights and Intelligence for the PPD clinical research business of Thermo Fisher Scientific.
Message PresenterWho Should Attend?
This webinar will appeal to executives and business service team members at biotech and biopharma companies, who will benefit from insights and industry trends presented.
Particular interest may exist for leaders in:
- Clinical Development
- Operations
- Peri-/post-approval
- Quality and Regulatory
- Preclinical Development
- Business services
- Commercial/Marketing
What You Will Learn
Attendees will learn:
- How today’s industry trends and challenges are shaping drug development in 2026, with insights to help navigate uncertainty and make faster, more strategic decisions
Xtalks Partner
The PPD clinical research business of Thermo Fisher Scientific Inc.
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, their capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, they serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, they apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account